Viral vector vaccines
Over the past two years, the SARS-CoV-2 pandemic has highlighted the impact that emerging pathogens can have on global health. The development of new and effective vaccine technologies is vital in the fight against such threats. Viral vectors are a relatively new vaccine platform that relies on reco...
Автори: | McCann, N, O'Connor, D, Lambe, T, Pollard, AJ |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Elseveir
2022
|
Схожі ресурси
Схожі ресурси
-
Clinical advances in viral-vectored influenza vaccines
за авторством: Sebastian, S, та інші
Опубліковано: (2018) -
Viral vectors as vaccine platforms: from immunogenicity to impact
за авторством: Ewer (nee Russell), K, та інші
Опубліковано: (2016) -
Clinical development of viral vectored vaccines against MERS-COV
за авторством: Ewer, K, та інші
Опубліковано: (2018) -
Viral vectors for malaria vaccine development.
за авторством: Li, S, та інші
Опубліковано: (2007) -
Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen
за авторством: Sheerin, D, та інші
Опубліковано: (2021)